| Titel | 6 Years’ Experience With HDR Brachytherapy In Bladder Implantations Performed Laparoscopically In Solitary Bladder Tumors. A Prospective Study |
| Auteurs | Elzbieta van der Steen-Banasik, Geert Smits, Bernard Oosterveld, Theo Janssen, Dorien Haverkort, Carl Wijburg, Andries Visser |
| Aandachtsgebied | Brachytherapie, Urologie |
| Doel | In our institution laparoscopic bladder implantations were performed since June 2009. In December 2009 a HDR schedule was introduced, replacing the former PDR schedule. In addition laparoscopy was modernized with the introduction of a robot. Here we report our 6 year experience. |
| Startdatum | 4 februari 2016 |
| Locatie | Arnhem |
| Link naar PubMed |
Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints
| Titel | Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints. |
| Auteurs | Peters M, van der Voort van Zyp J, Hoekstra C, Westendorp H, van de Pol S, Moerland M, Maenhout M, Kattevilder R, van Vulpen M. |
| Aandachtsgebied | Brachytherapy, Urologie |
| Samenvatting | Salvage Iodine-125 brachytherapy (I-125-BT) constitutes a curative treatment approach for patients with organ-confined recurrent prostate cancer after primary radiotherapy. Currently, focal salvage (FS) instead of whole-gland or total salvage (TS) is being investigated, to reduce severe toxicity associated with cumulative radiation dose. Differences in urethral and bladder dosimetry and constraints to reduce late (> 90 days) genitourinary (GU) toxicity are presented here. |
| Datum | september 2015 |
| Locatie | Radiother Oncol. 2015 Nov;117(2):262-9. doi: 10.1016/j.radonc.2015.08.018. Epub 2015 Sep 5. |
| Link naar PubMed |
Rectal dose constraints for salvage iodine-125 prostate brachytherapy.
| Titel | Rectal dose constraints for salvage iodine-125 prostate brachytherapy. |
| Auteurs | Peters M, Hoekstra CJ, van der Voort van Zyp JR, Westendorp H, van de Pol SM, Moerland MA, Maenhout M, Kattevilder R, van Vulpen M. |
| Aandachtsgebied | Brachytherapy, Urologie, Gastro-enterologie |
| Samenvatting | Organ-confined prostate cancer recurrences after primary radiotherapy can be treated with salvage iodine-125 brachytherapy. Options include total salvage (TS) or focal salvage (FS). TS often leads to severe late gastrointestinal (GI) toxicity. Differences in rectal dosimetry between TS and FS are presented and dose constraints proposed to reduce late severe GI toxicity (>90 days). |
| Datum | januari 2015 |
| Locatie | Brachytherapy. 2016 Jan-Feb;15(1):85-93. doi: 10.1016/j.brachy.2015.10.004. Epub 2015 Nov 21. |
| Link PubMed | Abstract |